Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with a type of ovarian cancer called epithelial ovarian cancer.
- People who had their primary (initial) cancer-removal surgery at the hospital running this trial.
- People whose cancer was confirmed after surgery to be at stage IIB or higher (meaning the cancer had spread beyond the early stages).
- People whose medical, surgical, and pathology records are largely complete and available.
Who may not be able to join:
- People whose ovarian cancer is a non-epithelial type (a different category of ovarian cancer).
- People who had fertility-preserving surgery (surgery aimed at keeping the ability to have children) or palliative surgery (surgery focused on relieving symptoms rather than removing the cancer).
- People who had an active infection at the time their PET/CT scan images were taken.
- People who have, or had, another type of cancer at the same time.
- People with serious conditions affecting other major organs (confirm with trial site for specific details on what qualifies).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: huaiwu Lu, The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phone: 86+ 18688395806
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
R0 resection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.